Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s41598-018-20304-5
Title: | Directed Differentiation of Adult Liver Derived Mesenchymal Like Stem Cells into Functional Hepatocytes | Authors: | Luo X. Gupta K. Ananthanarayanan A. Wang Z. Xia L. Li A. Sakban R.B. Liu S. Yu H. |
Keywords: | biological marker animal cell culture cell culture technique cell differentiation cell proliferation cytology flow cytometry liver liver cell male mesenchymal stem cell metabolism physiology procedures rat stem cell Wistar rat Animals Biomarkers Cell Culture Techniques Cell Differentiation Cell Proliferation Cells, Cultured Flow Cytometry Hepatocytes Liver Male Mesenchymal Stem Cells Rats Rats, Wistar Stem Cells |
Issue Date: | 2018 | Citation: | Luo X., Gupta K., Ananthanarayanan A., Wang Z., Xia L., Li A., Sakban R.B., Liu S., Yu H. (2018). Directed Differentiation of Adult Liver Derived Mesenchymal Like Stem Cells into Functional Hepatocytes. Scientific Reports 8 (1) : 2818. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-018-20304-5 | Abstract: | Shortage of functional hepatocytes hampers drug safety testing and therapeutic applications because mature hepatocytes cannot be expanded and maintain functions in vitro. Recent studies have reported that liver progenitor cells can originate from mature hepatocytes in vivo. Derivation of proliferating progenitor cells from mature hepatocytes, and re-differentiation into functional hepatocytes in vitro has not been successful. Here we report the derivation of novel mesenchymal-like stem cells (arHMSCs) from adult rat hepatocytes. Immunofluorescence and flow cytometry characterization of arHMSCs found expression of mesenchymal markers CD29, CD44, CD90, vimentin and alpha smooth muscle actin. These arHMSCs proliferated in vitro for 4 passages yielding 104 fold increase in cell number in 28 days, and differentiated into hepatocyte-like cells (arHMSC-H). The arHMSC-H expressed significantly higher level of hepatocyte-specific markers (200 fold for albumin and 6 fold for Cyp450 enzymes) than arHMSCs. The arHMSC-H also demonstrated dose response curves similar to primary hepatocytes for 3 of the 6 paradigm hepatotoxicants tested, demonstrating utility in drug safety testing applications. © 2018 The Author(s). | Source Title: | Scientific Reports | URI: | https://scholarbank.nus.edu.sg/handle/10635/175029 | ISSN: | 20452322 | DOI: | 10.1038/s41598-018-20304-5 |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1038_s41598-018-20304-5.pdf | 3.43 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.